Bank of New York Mellon’s Corvus Pharmaceuticals CRVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $443K | Buy |
+110,688
| New | +$443K | ﹤0.01% | 3555 |
|
|
2024
Q1 | – | Sell |
-21,219
| Closed | -$37.3K | – | 4183 |
|
|
2023
Q4 | $37.3K | Hold |
21,219
| – | – | ﹤0.01% | 4177 |
|
|
2023
Q3 | $31K | Hold |
21,219
| – | – | ﹤0.01% | 4203 |
|
|
2023
Q2 | $48.6K | Buy |
+21,219
| New | +$48.6K | ﹤0.01% | 4172 |
|
|
2019
Q2 | – | Sell |
-36,916
| Closed | -$149K | – | 4215 |
|
|
2019
Q1 | $149K | Sell |
36,916
-183
| -0.5% | -$739 | ﹤0.01% | 3930 |
|
|
2018
Q4 | $136K | Sell |
37,099
-175
| -0.5% | -$642 | ﹤0.01% | 3915 |
|
|
2018
Q3 | $320K | Buy |
37,274
+175
| +0.5% | +$1.5K | ﹤0.01% | 3796 |
|
|
2018
Q2 | $407K | Buy |
37,099
+9,782
| +36% | +$107K | ﹤0.01% | 3714 |
|
|
2018
Q1 | $315K | Sell |
27,317
-458
| -2% | -$5.28K | ﹤0.01% | 3771 |
|
|
2017
Q4 | $288K | Sell |
27,775
-85
| -0.3% | -$881 | ﹤0.01% | 3807 |
|
|
2017
Q3 | $444K | Sell |
27,860
-1,118
| -4% | -$17.8K | ﹤0.01% | 3632 |
|
|
2017
Q2 | $351K | Buy |
28,978
+13,023
| +82% | +$158K | ﹤0.01% | 3751 |
|
|
2017
Q1 | $331K | Buy |
+15,955
| New | +$331K | ﹤0.01% | 3715 |
|